Browse 522 autoimmune disorders clinical trials enrolling across the United States and Canada. 101 people applied to autoimmune disorders studies last month. Search by city or state to find one near you.
Autoimmune disorders occur when the immune system mistakenly attacks healthy tissues and organs in the body, leading to inflammation and a wide range of symptoms. Symptoms may include fatigue, joint pain, muscle weakness, skin rashes, digestive issues, and chronic inflammation. Clinical trials for autoimmune disorders explore new therapies aimed at reducing immune system activity, controlling symptoms, and improving long-term health outcomes. Autoimmune disorders may be connected to conditions like Lupus, Rheumatoid Arthritis, Multiple Sclerosis, Myasthenia Gravis, and Psoriasis — explore related condition trials below.
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
for
Graves Disease
Location: Morehead City NC, Greenville NC, Wilmington NC,
Sponsor: Biohaven Therapeutics Ltd.
Sex: All
Age: 18 - 70
Code: NCT07661056
Phase3, Recruiting
Dasatinib for HIV-1 Reservoir Reduction
for
HIV Infections
Location: Cleveland OH, Chicago IL, Seattle WA
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18+
Code: NCT07342491
Phase1, Recruiting
Hybrid Type I Effectiveness-Implementation Trial of a Social Network Support Intervention
for
HIV Seropositivity
Location: Huntsville AL, Birmingham AL, Chicago IL
Sponsor: University of Chicago
Sex: All
Age: 18 - 49
Code: NCT05723653
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
The TAIL-PrEP Study
for
HIV Infections
Location: New York NY
Sponsor: Columbia University
Sex: All
Age: 18+
Code: NCT06868641
Recruiting
Menopausal HT for Women Living With HIV (HoT)
for
HIV Infection, Menopause
Location: Boston MA, New York NY, Newark NJ, Philadelphia PA,
Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Sex: Female
Age: 40 - 60
Code: NCT06856174
Recruiting
Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706
for
HIV Infections
Location: Boston MA, Philadelphia PA, Nashville TN,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18 - 60
Code: NCT06665646
Phase1, Recruiting
A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
for
Immune Thrombocytopenia (ITP)
Location: Westbury NY, Washington D.C. DC, New Orleans LA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06721013
Phase1, Phase2, Recruiting
Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant
for
Acute Myeloid Leukemia, Graft Versus Host Disease,
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18 - 70+
Code: NCT06996119
Phase1, Recruiting
A Remotely Delivered Tai Chi/Qigong Intervention for Older People Living With HIV
for
Depressive Symptoms, Hiv
Location: Miami FL
Sponsor: Florida International University
Sex: All
Age: 50 - 70+
Code: NCT06586619
Recruiting
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
for
HIV
Location: San Francisco CA
Sponsor: University of California, San Francisco
Sex: All
Age: 18 - 70
Code: NCT01202305
Recruiting
Effectiveness Comparison of 3D-Printed and Conventional Ear Tip Comfort in Individuals With Hearing Loss
Location: New York NY, Montreal, Salt Lake City UT, Seattle WA,
Sponsor: Kite, A Gilead Company
Sex: All
Age: 18 - 70+
Code: NCT07304154
Phase1, Recruiting
Stick2PrEP Cisgender Women and Trans Individuals
for
HIV Prevention, Pre-exposure Prophylaxis
Location: New York NY
Sponsor: Columbia University
Sex: All
Age: 18+
Code: NCT05165745
Recruiting
Study of Ravulizumab in Pediatric Participants With Primary IgAN
for
IgAN, IgAVN, Immunoglobulin A Nephropathy,
Location: Aurora CO
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All
Age: 2 - 18
Code: NCT07024563
Phase3, Recruiting
Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...
for
HIV, Hematologic Malignancies
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 12 - 70+
Code: NCT05470491
Phase1, Phase2, Recruiting
Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning